Page last updated: 2024-08-25

rosiglitazone and Cholangiocarcinoma

rosiglitazone has been researched along with Cholangiocarcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, NS; Wei, DP; Wu, LH; Xiong, XZ	1

Other Studies

1 other study(ies) available for rosiglitazone and Cholangiocarcinoma

Article	Year
[Effect of PPAR-gamma ligand RGZ on inhibiting the cell proliferation of cholangiocarcinoma]. Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2007, Volume: 38, Issue:2 Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Dose-Response Relationship, Drug; Humans; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones; Time Factors	2007

Article

Year

[Effect of PPAR-gamma ligand RGZ on inhibiting the cell proliferation of cholangiocarcinoma].

Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2007, Volume: 38, Issue:2

Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Dose-Response Relationship, Drug; Humans; Ligands; PPAR gamma; Rosiglitazone; Thiazolidinediones; Time Factors

2007